Review highlights the role of macrophage metabolomics in identifying inflammatory markers and mechanisms, suggesting new targets for therapy.
Macrophages are the core effector cells of the innate immune system. The dysregulation of amino acid, glucose, lipid, and energy metabolism in macrophages has a profound impact on inflammatory pathways. A comprehensive analysis of metabolites in macrophages can identify inflammatory metabolic biomarkers, elucidate inflammatory metabolic pathways, and provide a deep understanding of inflammation. Metabolomics technology, as a high-throughput detection method for analyzing small molecule metabolites in the body, can reveal the relationship of metabolic networks by detecting changes in the metabolites of macrophages. Therefore, this review summarizes the application of metabolomics in macrophages, comprehensively elaborates the metabolic network within macrophages, and aims to provide a new perspective for the discovery of potential inflammatory biomarkers and therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: